Solitary Osteochondroma Treatment & Management
- Author: Ian D Dickey, MD, FRCSC; Chief Editor: Harris Gellman, MD more...
Medical Therapy
No medical therapy currently exists for osteochondromas. The mainstay of nonoperative treatment is observation because most lesions are asymptomatic. Lesions found incidentally can be observed, and the patient can be reassured.
Surgical Therapy
The treatment for symptomatic osteochondromas is resection. Care must be taken to ensure that none of the cartilage cap or perichondrium is left in the resection bed; otherwise, there may be a recurrence. Ideally, the line of resection should be through the base of the stalk; thus, the entire lesion is removed en bloc with its fibrous covering. Atypical or very large lesions should be investigated fully to exclude the remote possibility of malignancy. MRI is useful in assessing cartilage cap thickness.
In the skeletally immature patient, care must be taken to avoid damage to the growth plate during the exposure and resection of the lesion. One small study evaluated surgical outcomes of pediatric patients with osteochondroma of the digits; average age at surgery was 3.6 years. The study recommends early surgical treatment for patients with nonepiphyseal metaphysis of the bone to improve motion and to prevent further finger deformity. However, tumor excision, which may include part of the articular surface, is recommended when tumors are laterally oriented and include less than one third of the joint surface.[28]
Preoperative Details
Local anatomic constraints must be considered carefully so that the approach and resection do not damage nearby structures. CT scanning and MRI can be useful for lesions that arise from flat bones or that are located in difficult areas, such as lesions around the hip or scapula.[29]
Intraoperative Details
Once the osteochondroma is exposed, dissection is limited to the base of the lesion so that an osteotome can be used to shear off the base at the level of the host bone cortex. Care is required to ensure that the resection neither violates normal host cortex by straying too deep nor leaves residual lesion by staying too shallow. The overlying bursa should be left intact, and the loose adhesive tissue should be dissected away so that the lesion and the bursa are removed en bloc.
The resected surface of the host bone can be rasped smooth, and if needed, bone wax can be packed on the cut surface to stop bleeding.
Once the specimen is removed and pathologic confirmation is received, the wound should be irrigated well and a surgical drain can be placed if needed. The drain should exit in line with the wound.
Postoperative Details
Most osteochondromas allow the patient to return to activity as tolerated. However, after resection of a large sessile lesion, restriction of activities should be considered because the stress riser created by the violation of the cortex may increase the risk of fracture.
Follow-up
The local recurrence rate after resection of osteochondroma is about 1.8%.[30] Once the wound is healed, follow-up on an as-needed basis is reasonable if no associated bone deformity or potential growth-arrest concerns exist.
Complications
Complications after surgical resection of osteochondromas are rare. Considerations include physeal disturbance or growth arrest, fracture, recurrence, incorrect diagnosis, and hematoma formation.
Outcome and Prognosis
For solitary osteochondromas, the outcome and prognosis after surgery are excellent, with excellent local control and a local recurrence rate of less than 2%.[31, 5] The process is a benign one; thus, the prognosis is usually one of complete recovery. Poorer outcomes usually are related to the morbidity associated with the exposure required to remove the lesion or associated with secondary bone deformity, but the latter is usually observed in the multiple hereditary form of the disease.[32, 33, 34, 35, 36, 37, 38]
Future and Controversies
Genetic karyotyping suggests that reproducible genetic abnormalities are associated with these benign growths and that they may represent a true neoplastic process, not a reactive one.[10, 11] Research is in the early stages, and further investigation is needed.[12, 13, 14, 15] Biologic therapies for osteochondromas may be possible in the future.
Garrison RC, Unni KK, McLeod RA, Pritchard DJ, Dahlin DC. Chondrosarcoma arising in osteochondroma. Cancer. May 1 1982;49(9):1890-7. [Medline].
Staals EL, Bacchini P, Mercuri M, Bertoni F. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas. J Bone Joint Surg Am. May 2007;89(5):987-93. [Medline].
Akahane T, Shimizu T, Isobe K, Yoshimura Y, Kato H. Dedifferentiated chondrosarcoma arising in a solitary osteochondroma with leiomyosarcomatous component: a case report. Arch Orthop Trauma Surg. Jan 12 2008;[Medline].
Purandare NC, Rangarajan V, Agarwal M, Sharma AR, Shah S, Arora A, et al. Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas. Clin Nucl Med. Jun 2009;34(6):350-4. [Medline].
Florez B, Mönckeberg J, Castillo G, Beguiristain J. Solitary osteochondroma long-term follow-up. J Pediatr Orthop B. Mar 2008;17(2):91-4. [Medline].
Heinritz W, Hüffmeier U, Strenge S, Miterski B, Zweier C, Leinung S, et al. New mutations of EXT1 and EXT2 genes in German patients with Multiple Osteochondromas. Ann Hum Genet. May 2009;73:283-91. [Medline].
Mavrogenis AF, Papagelopoulos PJ, Soucacos PN. Skeletal osteochondromas revisited. Orthopedics. Oct 2008;31(10):[Medline].
Nogier A, De Pinieux G, Hottya G, Anract P. Case reports: enlargement of a calcaneal osteochondroma after skeletal maturity. Clin Orthop Relat Res. Jun 2006;447:260-6. [Medline].
D'Ambrosia R, Ferguson AB Jr. The formation of osteochondroma by epiphyseal cartilage transplantation. Clin Orthop. Nov-Dec 1968;61:103-15. [Medline].
Hameetman L, Szuhai K, Yavas A, Knijnenburg J, van Duin M, van Dekken H, et al. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst. Mar 7 2007;99(5):396-406. [Medline].
Hecht JT, Hogue D, Strong LC, et al. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. May 1995;56(5):1125-31. [Medline].
Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD. p53 expression and DNA ploidy of cartilage lesions. Hum Pathol. Jun 1995;26(6):620-4. [Medline].
Legeai-Mallet L, Margaritte-Jeannin P, Lemdani M, et al. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet. Mar 1997;99(3):298-302. [Medline].
Legeai-Mallet L, Munnich A, Maroteaux P, et al. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet. Jul 1997;52(1):12-6. [Medline].
Park KJ, Shin KH, Ku JL. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses. J Hum Genet. 1999;44(4):230-4. [Medline].
Kitsoulis P, Galani V, Stefanaki K, Paraskevas G, Karatzias G, Agnantis NJ, et al. Osteochondromas: review of the clinical, radiological and pathological features. In Vivo. Sep-Oct 2008;22(5):633-46. [Medline].
Galasso O, Mariconda M, Milano C. An enlarging distal tibia osteochondroma in the adult patient. J Am Podiatr Med Assoc. Mar-Apr 2009;99(2):157-61. [Medline].
Coenen L, Biltjes I. High radial nerve palsy caused by a humeral exostosis: a case report. J Hand Surg [Am]. Jul 1992;17(4):668-9. [Medline].
Mnif H, Koubaa M, Zrig M, Zammel N, Abid A. Peroneal nerve palsy resulting from fibular head osteochondroma. Orthopedics. Jul 2009;32(7):528. [Medline].
Karasick D, Schweitzer ME, Eschelman DJ. Symptomatic osteochondromas: imaging features. AJR Am J Roentgenol. Jun 1997;168(6):1507-12. [Medline].
Murphey MD, Choi JJ, Kransdorf MJ, Flemming DJ, Gannon FH. Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics. Sep-Oct 2000;20(5):1407-34. [Medline].
El-Khoury GY, Bassett GS. Symptomatic bursa formation with osteochondromas. AJR Am J Roentgenol. Nov 1979;133(5):895-8. [Medline].
Day FN, Ruggieri C, Britton C. Recurrent osteochondroma. J Foot Ankle Surg. Mar-Apr 1998;37(2):162-4; discussion 173. [Medline].
Robbin MR, Murphey MD. Benign chondroid neoplasms of bone. Semin Musculoskelet Radiol. 2000;4(1):45-58. [Medline].
Hudson TM, Springfield DS, Spanier SS, et al. Benign exostoses and exostotic chondrosarcomas: evaluation of cartilage thickness by CT. Radiology. Sep 1984;152(3):595-9. [Medline].
Lange RH, Lange TA, Rao BK. Correlative radiographic, scintigraphic, and histological evaluation of exostoses. J Bone Joint Surg Am. Dec 1984;66(9):1454-9. [Medline].
Robinson D, Hasharoni A, Oganesian A, et al. Role of FGF9 and FGF receptor 3 in osteochondroma formation. Orthopedics. Aug 2001;24(8):783-7. [Medline].
Ohnishi T, Horii E, Shukuki K, Hattori T. Surgical treatment for osteochondromas in pediatric digits. J Hand Surg Am. Mar 2011;36(3):432-8. [Medline].
Fageir MM, Edwards MR, Addison AK. The surgical management of osteochondroma on the ventral surface of the scapula. J Pediatr Orthop B. Sep 1 2009;[Medline].
Humbert ET, Mehlman C, Crawford AH. Two cases of osteochondroma recurrence after surgical resection. Am J Orthop. Jan 2001;30(1):62-4. [Medline].
Chin KR, Kharrazi FD, Miller BS, Mankin HJ, Gebhardt MC. Osteochondromas of the distal aspect of the tibia or fibula. Natural history and treatment. J Bone Joint Surg Am. Sep 2000;82(9):1269-78. [Medline].
Fogel GR, McElfresh EC, Peterson HA, Wicklund PT. Management of deformities of the forearm in multiple hereditary osteochondromas. J Bone Joint Surg Am. Jun 1984;66(5):670-80. [Medline].
Govender S, Parbhoo AH. Osteochondroma with compression of the spinal cord. A report of two cases. J Bone Joint Surg Br. Jul 1999;81(4):667-9. [Medline].
Peterson HA. Multiple hereditary osteochondromata. Clin Orthop. Feb 1989;(239):222-30. [Medline].
Porter DE, Benson MK, Hosney GA. The hip in hereditary multiple exostoses. J Bone Joint Surg Br. Sep 2001;83(7):988-95. [Medline].
Snearly WN, Peterson HA. Management of ankle deformities in multiple hereditary osteochondromata. J Pediatr Orthop. Jul-Aug 1989;9(4):427-32. [Medline].
Wuyts W, Ramlakhan S, Van Hul W. Refinement of the multiple exostoses locus (EXT2) to a 3-cM interval on chromosome 11. Am J Hum Genet. Aug 1995;57(2):382-7. [Medline].
Wicklund CL, Pauli RM, Johnston D. Natural history study of hereditary multiple exostoses. Am J Med Genet. Jan 2 1995;55(1):43-6. [Medline].

